[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SnupSnus Simon L
Simon L posts on X about $nams, $bbio, $cytk, aes the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX +72%
- X Month XXXXX +136%
- X Months XXXXXX -XX%
- X Year XXXXXX -XX%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +0.31%
- X Month XXXXX +1.90%
- X Months XXXXX +3.90%
- X Year XXXXX +4.60%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance
Social topic influence $nams, $bbio, $cytk, aes, compare the, theres a
Top assets mentioned BridgeBio Pharma, Inc. Common Stock (BBIO) Cytokinetics Inc. (CYTK)
Top Social Posts #
Top posts by engagements in the last XX hours
"Reduced $BBIO a bit (1/5 -now just shy of 20%) and added some $NAMS- the Alz data (remember: w.o. cognition or brain imaging) might be Meme moment. not sure tbh about Overall and CVOT prospects -even though I have been doing loads of reading-"
@SnupSnus on X 2025-07-25 15:25:23 UTC 1640 followers, XXX engagements
"@Andre_AGTC I like-correct me if I am wrong- how your portfolio is so focused on the lifeblood of the sector: the buyout Notably absent $CYTK and radiopharma- is that for specific reasons" @SnupSnus on X 2025-07-24 00:57:02 UTC 1639 followers, XXX engagements
"@JialiangLiang @seedy19tron I am not saying that there's a "safety issue" w Rinvoq but it carries a (class) black box (a class too IRCC) CV-mortality label and all in all just compare the AE's -ENTYVIO might be the closest to pbo like safety in drug development we got so far-this is why it's King in IBD" @SnupSnus on X 2025-07-26 04:35:15 UTC 1640 followers, XXX engagements